by rss feed | Nov 24, 2024 | GIOSTAR, News Feeds, Ossium Health, weekly reads
What happens if unproven stem cell clinic firms like GIOSTAR start getting okays from the FDA to do clinical trials? On the one hand, it could reflect a positive trend of stem cell clinic firms working with the FDA and toward compliance. Having more robust data....
